Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Ekblond

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|December 29, 2022
Optimizing an immunomodulatory potency assay for Mesenchymal Stromal CellStine Bangsgaard Hansen, Lisbeth Drozd Højgaard, Jens Kastrup, et al.
Journal of Translational Medicine|September 20, 2013
Identical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart diseaseBjarke Follin, Josefine Tratwal, Mandana Haack-Sørensen, et al.
American Heart Journal|September 18, 2012
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)Anders Bruun Mathiasen, Erik Jørgensen, Abbas Ali Qayyum, et al.
Regenerative Medicine|May 19, 2012
Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study designAbbas Ali Qayyum, Mandana Haack-Sørensen, Anders Bruun Mathiasen, et al.
Scandinavian Cardiovascular Journal : SCJ|July 7, 2016
Mesenchymal stromal cell therapy in ischemic heart diseaseJens Kastrup, Naja Dam Mygind, Abbas Ali Qayyum, et al.
Cytotherapy|June 3, 2015
Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: Phenotypic and immunomodulatory evaluationBjarke Follin, Morten Juhl, Smadar Cohen, et al.
Biomedicines|December 9, 2020
Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic ReviewCecilie Hoeeg, Sabina Frljak, Abbas Ali Qayyum, et al.
Stem Cell Reviews and Reports|May 31, 2012
Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansionMandana Haack-Sørensen, Susanne Kofoed Hansen, Louise Hansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 18, 2018
Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysateMandana Haack-Sørensen, Morten Juhl, Bjarke Follin, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 25, 2017
Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatmentAbbas Ali Qayyum, Kamal Preet Kaur, Anders Bruun Mathiasen, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|December 29, 2022
Optimizing an immunomodulatory potency assay for Mesenchymal Stromal CellStine Bangsgaard Hansen, Lisbeth Drozd Højgaard, Jens Kastrup, et al.
Journal of Translational Medicine|September 20, 2013
Identical effects of VEGF and serum-deprivation on phenotype and function of adipose-derived stromal cells from healthy donors and patients with ischemic heart diseaseBjarke Follin, Josefine Tratwal, Mandana Haack-Sørensen, et al.
American Heart Journal|September 18, 2012
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial)Anders Bruun Mathiasen, Erik Jørgensen, Abbas Ali Qayyum, et al.
Regenerative Medicine|May 19, 2012
Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study designAbbas Ali Qayyum, Mandana Haack-Sørensen, Anders Bruun Mathiasen, et al.
Scandinavian Cardiovascular Journal : SCJ|July 7, 2016
Mesenchymal stromal cell therapy in ischemic heart diseaseJens Kastrup, Naja Dam Mygind, Abbas Ali Qayyum, et al.
Cytotherapy|June 3, 2015
Human adipose-derived stromal cells in a clinically applicable injectable alginate hydrogel: Phenotypic and immunomodulatory evaluationBjarke Follin, Morten Juhl, Smadar Cohen, et al.
Biomedicines|December 9, 2020
Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic ReviewCecilie Hoeeg, Sabina Frljak, Abbas Ali Qayyum, et al.
Stem Cell Reviews and Reports|May 31, 2012
Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansionMandana Haack-Sørensen, Susanne Kofoed Hansen, Louise Hansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 18, 2018
Development of large-scale manufacturing of adipose-derived stromal cells for clinical applications using bioreactors and human platelet lysateMandana Haack-Sørensen, Morten Juhl, Bjarke Follin, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|July 25, 2017
Influence of patient related factors on number of mesenchymal stromal cells reached after in vitro culture expansion for clinical treatmentAbbas Ali Qayyum, Kamal Preet Kaur, Anders Bruun Mathiasen, et al.
Pageof 6